Vanda Pharmaceuticals
VNDA
#7861
Rank
HK$2.47 B
Marketcap
HK$41.96
Share price
3.65%
Change (1 day)
12.81%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$1.05 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are HK$1.05 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$0.91 B12.97%
2023-12-31HK$0.80 B-3.33%
2022-12-31HK$0.83 B20.71%
2021-12-31HK$0.69 B11.47%
2020-12-31HK$0.62 B9.64%
2019-12-31HK$0.56 B27.68%
2018-12-31HK$0.44 B-23.23%
2017-12-31HK$0.57 B-5.63%
2016-12-31HK$0.61 B-1.17%
2015-12-31HK$0.62 B634.49%
2014-12-31HK$84.44 M-89.02%
2013-12-31HK$0.76 B-20.93%
2012-12-31HK$0.97 B-15.99%
2011-12-31HK$1.15 B-15.12%
2010-12-31HK$1.36 B-13.16%
2009-12-31HK$1.57 B5096.54%
2008-12-31HK$30.24 M-70.46%
2007-12-31HK$0.10 B38.53%
2006-12-31HK$73.91 M87.37%
2005-12-31HK$39.44 M180.66%
2004-12-31HK$14.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
HK$486.82 B 46,175.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$709.05 B 67,299.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 83,915.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.44 B 57,831.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$900.17 B 85,466.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
HK$2.04 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$604.38 B 57,350.37%๐Ÿ‡บ๐Ÿ‡ธ USA